Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 19

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 19
---
 |  1.66 | % |     |              | 100 | % |     |            | 42.51 | % |

| * | Less than 1%. |

| (1) | The principal address of the named officers, directors and 5% stockholders                                 
 of the Company is c/o Healthcare Triangle, Inc., 7901 Stoneridge Drive, Suite 

# 220, Pleasanton, CA 94588. |
| (2) | Entitles the holder to 1,000 votes per share and votes with the common                                     
 stocks as a single class.                                                                                  |
| (3) | Represents total ownership percentage with respect to all shares of                                        
 common stock, options and Series A Super Voting Preferred Stock, as a single class.                        |
| (4) | SecureKloud Technologies, Inc. is 60.7% owned by SecureKloud Technologies                                  
 Limited which is a publicly traded company in India.                                                       |
| (5) | Includes 42,961 shares of our common stock underlying stock options                                        
 that have vested or exerciseable within 60 days of February 24, 2025.                                      |
| (6) | Includes 19,152 shares of our common stock underlying stock options                                        
 that have vested or exerciseable within 60 days of February 24, 2025.                                      |
| (7) | Includes 19,152 shares of our common stock underlying stock options                                        
 that have vested or exerciseable within 60 days of February 24, 2025.                                      |
| (8) | Includes 65,000 shares of our common stock underlying stock options                                        
 that have vested or exerciseable within 60 days of February 24, 2025.                                      |

<div align='center'>11

INTERESTS OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON</div>

No person who has been our officer or director,
or to our knowledge, any of their associates, has any substantial interest, direct or indirect, by security holdings or otherwise in
any matter to be acted upon. None of our directors opposed the actions to be taken by the Company.

<div align='center'>VOTE OBTAINED — DELAWARE LAW</div>

Section 228 of the DGCL generally provides that
any action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote,
if a written consent thereto is signed by